Par Drugs and Chemicals Limited (PAR) Stock Statistics & Valuation Metrics

Par Drugs and Chemicals Limited has a market cap or net worth of ₹1.12B. The enterprise value is ₹781.90M.

Par Drugs and Chemicals Limited has 12,304,636 shares outstanding. The number of shares has decreased by -2.65% in one year.

Par Drugs and Chemicals Limited’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 11.62%.

The current PE Ratio of Par Drugs and Chemicals Limited is 6.5. Par Drugs and Chemicals Limited’s PEG ratio is -1.02.

In the last 12 months, Par Drugs and Chemicals Limited had revenue of 1.01B and earned 133.58M in profits. Earnings per share was 10.86.

In the last 12 months, operating cash flow was 80.95M and capital expenditures -7.21M, giving a free cash flow of 73.74M billion.

Par Drugs and Chemicals Limited pays an annual dividend of ₹1.25, resulting in a dividend yield of ―

Par Drugs and Chemicals Limited upcoming earnings date is May 7, 2026, Before Open (Confirmed).

Par Drugs and Chemicals Limited as a current ratio of 3.31, with Debt / Equity ratio of 0.00%

In the past 12 months, Par Drugs and Chemicals Limited has paid 45.65M in taxes.

Par Drugs and Chemicals Limited EV to EBITDA ratio is 4.05, with an EV/FCF ratio of 5.29.

Par Drugs and Chemicals Limited has ₹338.56M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹338.56M billion.

Gross margin is 56.22%, with operating margin of 15.87%, and net profit margin of 13.23%.

The average price target for Par Drugs and Chemicals Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―